Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The treatment was not recommended due to limited effectiveness and significant side effects.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Rampai leaves extract can significantly stimulate hair growth.

Betamethasone valerate lotion is more effective for treating multiple patchy alopecia areata.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Labrasol® in phospholipid vesicles improves minoxidil delivery to the skin, potentially aiding hair growth treatments.

Alopecia areata in Spain has a significant impact with unmet treatment needs and high costs.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

4-aminopyridine speeds up and improves skin wound healing.

Betamethasone lotion works better for patchy hair loss.

Sandalore, a synthetic scent, was found to reduce hair loss and improve hair growth in women with hair shedding issues.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Rivaroxaban and fondaparinux are effective for certain blood conditions, and hydroxyurea helps in sickle cell disease.

Minoxidil can cause severe body swelling and fluid buildup, which improves after stopping the drug and using diuretics.

The rash resolved after stopping ponatinib.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

AQB reduces harmful skin changes in systemic sclerosis.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.